Guangdong Lifestrong Pharmacy Co. Ltd. Market Cap ($376.95 Million)
Market Cap & Net Worth: Guangdong Lifestrong Pharmacy Co. Ltd. (301111)
Guangdong Lifestrong Pharmacy Co. Ltd. market cap. Guangdong Lifestrong Pharmacy Co. Ltd. (SHE:301111) has a market capitalization of $376.95 Million (CN¥2.58 Billion) as of November 1, 2026. Listed on the SHE stock exchange, this China-based company holds position #13379 globally and #3895 in its home market, demonstrating a -12.64% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Guangdong Lifestrong Pharmacy Co. Ltd.'s stock price CN¥16.10 by its total outstanding shares 160000000 (160.00 Million). Also see cash flow conversion of Guangdong Lifestrong Pharmacy Co. Ltd. for how efficiently the company converts equity into cash flow.
Guangdong Lifestrong Pharmacy Co. Ltd. Market Cap History (2021–2026)
Guangdong Lifestrong Pharmacy Co. Ltd. market cap history from 2021 to 2026. Data shows change from $1.11 Billion to $376.95 Million (-13.32% CAGR). Check 301111 share price today for real-time trading data and today's change.
Guangdong Lifestrong Pharmacy Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Guangdong Lifestrong Pharmacy Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 301111 net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.42x
Guangdong Lifestrong Pharmacy Co. Ltd.'s market cap is 1.42 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.11 Billion | $349.79 Million | $57.18 Million | 3.18x | 19.43x |
| 2022 | $454.43 Million | $283.34 Million | $33.42 Million | 1.60x | 13.60x |
| 2023 | $571.54 Million | $292.40 Million | $33.50 Million | 1.95x | 17.06x |
| 2024 | $381.16 Million | $278.64 Million | $4.16 Million | 1.37x | 91.57x |
| 2025 | $445.55 Million | $314.64 Million | -$4.49 Million | 1.42x | N/A |
Competitor Companies of 301111 by Market Capitalization
Companies near Guangdong Lifestrong Pharmacy Co. Ltd. in the global market cap rankings as of November 1, 2026. Also see total assets of Guangdong Lifestrong Pharmacy Co. Ltd. for a full breakdown of the balance sheet.
Key companies related to Guangdong Lifestrong Pharmacy Co. Ltd. by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of Guangdong Lifestrong Pharmacy Co. Ltd. (2021–2026)
Market capitalization of Guangdong Lifestrong Pharmacy Co. Ltd. from 2021 to today. Between 2021 and today, Guangdong Lifestrong Pharmacy Co. Ltd.'s market cap moved from $1.11 Billion to $ 376.95 Million, with a yearly change of -13.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥376.95 Million | -15.40% |
| 2025 | CN¥445.55 Million | +16.89% |
| 2024 | CN¥381.16 Million | -33.31% |
| 2023 | CN¥571.54 Million | +25.77% |
| 2022 | CN¥454.43 Million | -59.09% |
| 2021 | CN¥1.11 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Guangdong Lifestrong Pharmacy Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $376.95 Million USD |
| MoneyControl | $376.95 Million USD |
| MarketWatch | $376.95 Million USD |
| marketcap.company | $376.95 Million USD |
| Reuters | $376.95 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Guangdong Lifestrong Pharmacy Co. Ltd.
Guangdong Lifestrong Pharmacy Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products. It operates through Medical Services and Health Management; and Health Consumer Products segments. The company produces tablets, hard capsules, injections, and pills, and other related products. It also offers respiratory, pediatric, gynecology, urinary, and nutrition and… Read more